Disorders related to PI3Kδ hyperactivation: characterizing the clinical and immunological features of activated PI3-kinase delta syndromes

V Redenbaugh, T Coulter - Frontiers in Pediatrics, 2021 - frontiersin.org
Phosphoinositide-3-kinase δ (PI3Kδ) is found in immune cells and is part of the
PI3K/AKT/mTOR/S6K signalling pathway essential to cell survival, growth and differentiation …

Biosensors for the detection of protein kinases: Recent progress and challenges

N Fathi, A Saadati, M Alimohammadi… - Microchemical …, 2022 - Elsevier
Protein kinases act as a trigger for regulating a wide range of cellular processes including
development, survival, apoptosis, control of metabolism, transcription signals, and beyond …

Two cases of successful sirolimus treatment for patients with activated phosphoinositide 3-kinase δ syndrome 1

L Jiang, X Hu, Q Lin, R Chen, Y Shen, Y Zhu… - Allergy, Asthma & …, 2023 - Springer
Background Activated phosphoinositide3-kinase (PI3K) δ syndrome 1 (APDS1) is a novel
inborn errors of immunity (IEIs) caused by heterozygous gain of function mutations in PI3Kδ …

Interstitial lung disease in immunocompromised children

X Gao, K Michel, M Griese - Diagnostics, 2022 - mdpi.com
Background: The range of pulmonary complications beyond infections in pediatric
immunocompromised patients is broad but not well characterized. Our goal was to assess …

Genetic Etiologies and Outcomes in Malignancy and Mortality in Activated Phosphoinositide 3-Kinase Delta Syndrome: A Systematic Review

K Büsch, HL Memmott, HM McLaughlin, JEM Upton… - Advances in …, 2024 - Springer
Methods A systematic review was performed according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses approach, including all articles published in English …

Infections in Disorders of Immune Regulation

A Thangaraj, R Tyagi, D Suri, S Gupta - Pathogens, 2024 - mdpi.com
Primary immune regulatory disorders (PIRDs) constitute a spectrum of inborn errors of
immunity (IEIs) that are primarily characterized by autoimmunity, lymphoproliferation, atopy …

Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era

F Barzaghi, M Moratti, G Panza, B Rivalta… - Journal of Clinical …, 2025 - Springer
Abstract Background Activated Phosphoinositide 3-Kinase (PI3K) δ Syndrome (APDS), an
inborn error of immunity due to upregulation of the PI3K pathway, leads to recurrent …

Phenotypic and Immunological Characterization of Patients with Activated PI3Kδ Syndrome 1 Presenting with Autoimmunity

Q Li, W Wang, Q Wu, Q Zhou, W Ying, X Hui… - Journal of Clinical …, 2024 - Springer
Purpose Autoimmunity is a significant feature of APDS1 patients. We aimed to explore the
pathogenic immune phenotype and possible mechanisms of autoimmunity in APDS1 …

A single center experience on PI3K/AKT/MTOR signaling defects: Towards pathogenicity assessment for four novel defects

HN Bildik, S Esenboga, SO Halaclı… - Pediatric Allergy and …, 2024 - Wiley Online Library
Abstract Background Phosphoinositide 3 kinases (PI3K) are lipid kinases expressed in
lymphocytes/myeloid cells. PI3K/AKT/mTOR signaling defects present with recurrent …

Clinical and immunological assessment of APDS2 with features of the SHORT syndrome related to a novel mutation in PIK3R1 with reduced penetrance

A Szczawińska-Popłonyk, K Bernat-Sitarz… - Allergologia et …, 2022 - all-imm.com
Monoallelic loss-of-function (LOF) mutations in the phosphatidylinositol 3-kinase (PIK3R1)
gene affecting the inter-Src homology 2 domain of the p85α regulatory subunit of …